Skip to main content
NVDA-2.39%AAPL+2.31%GOOGL+0.10%MSFT-0.02%AMZN+0.06%TSM-0.72%SPCX+1.69%AVGO-0.04%META+0.40%TSLA-0.45%SKHY-3.99%MU-4.17%BRK-B-0.06%LLY+0.40%JPM-0.38%AMD-2.33%WMT+0.16%V-0.25%XOM-0.26%ASMLa-1.56%JNJ-0.22%INTC-4.20%MA-0.59%0700.HK-1.94%ORCL-2.03%1398.HK+0.79%BAC-0.26%ABBV+0.52%CSCO-0.44%CVX-0.51%COST-0.10%LRCX-3.66%KO+0.59%CAT-0.99%AMAT-2.21%0005.HK-0.78%AP2d-1.57%UNH-0.63%DELL-2.88%HSBA.L-1.01%MS+0.01%PG-0.28%GE+0.11%3988.HK+0.84%1816.HK+0.23%0857.HK-3.26%NFLX-0.34%HD-1.11%GS-0.18%0939.HK+1.66%NZDJPY-2.68%AUDJPY-1.96%CHFJPY-1.68%USDJPY-1.50%GBPJPY-1.39%EURJPY-1.37%CADJPY-1.36%EURNZD+1.36%NZDCAD-1.34%GBPNZD+1.31%NZDUSD-1.21%NZDCHF-1.04%USDNOK+0.91%EURNOK+0.87%CHFNOK+0.78%AUDNZD+0.75%USDZAR+0.68%USDSEK+0.68%NOKJPY-0.67%EURZAR+0.64%EURSEK+0.64%AUDDKK-0.63%AUDCAD-0.62%EURAUD+0.60%GBPAUD+0.55%GBPZAR+0.55%CHFSEK+0.54%AUDSGD-0.50%AUDUSD-0.46%USDTHB+0.45%USDMXN+0.42%GBPTRY+0.41%NZDSGD-0.32%GBPHKD+0.32%EURCHF+0.31%CADCHF+0.30%GBPMXN-0.28%AUDCHF-0.28%GBPCHF+0.27%USDPLN+0.25%AUDNOK+0.24%EURPLN+0.20%USDCHF+0.19%USDILS+0.16%USDSGD+0.16%EURUSD+0.13%USDCAD-0.12%EURSGD+0.12%GBPUSD+0.11%USDTRY+0.11%EURCZK-0.09%NZDMXN-0.08%SGDJPY+0.07%USDCNH+0.05%EURHKD-0.05%EURGBP+0.04%GBPCAD-0.04%USDCOP-0.04%EURCNH+0.04%USDDKK+0.03%GBPSGD+0.03%CHFSGD+0.03%USDHKD+0.01%PLNJPY-0.01%EURDKK-0.01%EURCAD0.00%XPTUSD-4.74%HG1-4.47%GAGUSD-4.15%XAGUSD-4.14%UKOIL+3.54%USOIL+3.11%SUGAR+1.50%XAUUSD-0.98%GAUUSD-0.98%COFFEE-0.76%COTTON+0.66%S1+0.65%BTCUSD-1.21%ETHUSD-1.02%USDTUSD-0.02%XRPUSD-2.60%SOLUSD-1.48%TRXUSDT0.00%ZECUSDT-5.54%DOGEUSD-2.81%XMRUSDT-1.66%LINKUSD-1.09%XLMUSD-1.92%BCHUSDT-10.38%LTCUSD-1.72%UNIUSD-3.29%TONUSD+24.88%HBARUSDT-1.85%SUIUSD-3.41%TAOUSDT-5.10%AAVEUSD-2.76%DOTUSDT-3.34%ICPUSDT-0.79%ONDOUSDT-2.76%WLDUSDT-2.43%ATOMUSDT-3.35%ARBUSDT+1.64%JUPUSDT-2.96%INJUSDT-4.80%STXUSDT-3.07%FETUSDT-3.57%TIAUSDT-0.87%PYTHUSDT+0.14%SEIUSDT-3.91%IMXUSDT-3.85%GRTUSDT-2.94%WIFUSDT-4.40%OPUSDT-3.00%IOTAUSDT-3.76%POLUSDT-5.71%AXSUSDT-2.47%FARTCOINUSDT-2.75%EOSUSDT-0.93%DYDXUSDT-0.80%ORDIUSDT-0.83%GALAUSDT-4.78%NOTUSDT-2.97%RONINUSDT-2.64%NVDA-2.39%AAPL+2.31%GOOGL+0.10%MSFT-0.02%AMZN+0.06%TSM-0.72%SPCX+1.69%AVGO-0.04%META+0.40%TSLA-0.45%SKHY-3.99%MU-4.17%BRK-B-0.06%LLY+0.40%JPM-0.38%AMD-2.33%WMT+0.16%V-0.25%XOM-0.26%ASMLa-1.56%JNJ-0.22%INTC-4.20%MA-0.59%0700.HK-1.94%ORCL-2.03%1398.HK+0.79%BAC-0.26%ABBV+0.52%CSCO-0.44%CVX-0.51%COST-0.10%LRCX-3.66%KO+0.59%CAT-0.99%AMAT-2.21%0005.HK-0.78%AP2d-1.57%UNH-0.63%DELL-2.88%HSBA.L-1.01%MS+0.01%PG-0.28%GE+0.11%3988.HK+0.84%1816.HK+0.23%0857.HK-3.26%NFLX-0.34%HD-1.11%GS-0.18%0939.HK+1.66%NZDJPY-2.68%AUDJPY-1.96%CHFJPY-1.68%USDJPY-1.50%GBPJPY-1.39%EURJPY-1.37%CADJPY-1.36%EURNZD+1.36%NZDCAD-1.34%GBPNZD+1.31%NZDUSD-1.21%NZDCHF-1.04%USDNOK+0.91%EURNOK+0.87%CHFNOK+0.78%AUDNZD+0.75%USDZAR+0.68%USDSEK+0.68%NOKJPY-0.67%EURZAR+0.64%EURSEK+0.64%AUDDKK-0.63%AUDCAD-0.62%EURAUD+0.60%GBPAUD+0.55%GBPZAR+0.55%CHFSEK+0.54%AUDSGD-0.50%AUDUSD-0.46%USDTHB+0.45%USDMXN+0.42%GBPTRY+0.41%NZDSGD-0.32%GBPHKD+0.32%EURCHF+0.31%CADCHF+0.30%GBPMXN-0.28%AUDCHF-0.28%GBPCHF+0.27%USDPLN+0.25%AUDNOK+0.24%EURPLN+0.20%USDCHF+0.19%USDILS+0.16%USDSGD+0.16%EURUSD+0.13%USDCAD-0.12%EURSGD+0.12%GBPUSD+0.11%USDTRY+0.11%EURCZK-0.09%NZDMXN-0.08%SGDJPY+0.07%USDCNH+0.05%EURHKD-0.05%EURGBP+0.04%GBPCAD-0.04%USDCOP-0.04%EURCNH+0.04%USDDKK+0.03%GBPSGD+0.03%CHFSGD+0.03%USDHKD+0.01%PLNJPY-0.01%EURDKK-0.01%EURCAD0.00%XPTUSD-4.74%HG1-4.47%GAGUSD-4.15%XAGUSD-4.14%UKOIL+3.54%USOIL+3.11%SUGAR+1.50%XAUUSD-0.98%GAUUSD-0.98%COFFEE-0.76%COTTON+0.66%S1+0.65%BTCUSD-1.21%ETHUSD-1.02%USDTUSD-0.02%XRPUSD-2.60%SOLUSD-1.48%TRXUSDT0.00%ZECUSDT-5.54%DOGEUSD-2.81%XMRUSDT-1.66%LINKUSD-1.09%XLMUSD-1.92%BCHUSDT-10.38%LTCUSD-1.72%UNIUSD-3.29%TONUSD+24.88%HBARUSDT-1.85%SUIUSD-3.41%TAOUSDT-5.10%AAVEUSD-2.76%DOTUSDT-3.34%ICPUSDT-0.79%ONDOUSDT-2.76%WLDUSDT-2.43%ATOMUSDT-3.35%ARBUSDT+1.64%JUPUSDT-2.96%INJUSDT-4.80%STXUSDT-3.07%FETUSDT-3.57%TIAUSDT-0.87%PYTHUSDT+0.14%SEIUSDT-3.91%IMXUSDT-3.85%GRTUSDT-2.94%WIFUSDT-4.40%OPUSDT-3.00%IOTAUSDT-3.76%POLUSDT-5.71%AXSUSDT-2.47%FARTCOINUSDT-2.75%EOSUSDT-0.93%DYDXUSDT-0.80%ORDIUSDT-0.83%GALAUSDT-4.78%NOTUSDT-2.97%RONINUSDT-2.64%
RP

Rigel Pharmaceuticals, Inc. (RIGL)

NASDAQ • Healthcare

$47.22
-$0.14 (-0.3%)
Market open

Last close at September 9, 2026 at 20:00 UTC

Open$46.85
Previous Close$47.22
Day Range$46.78 - $47.88
Avg. Volume (3M)290.4K
Market Cap$873.6M
P/E Ratio2.7
52 Week Range
$24.95$52.24
Next EarningsIn 54 daysNov 3, 2026

Metrics Over Time

Where the Money Goes

Q2 2026
Revenueeverything earned$78.7M100%
Gross Profitminus cost of goods$70.1M89%
Operating Incomeminus R&D and overhead$23.5M30%
Net Incomeminus taxes and the rest$17.2M22%

In plain terms: out of every $100 in revenue, Rigel Pharmaceuticals, Inc. keeps $22 as net profit.

Fundamentals & Financials

Revenue (TTM)
$276.7M
Net Income (TTM)
$321.9M
EPS (TTM)
$17.67
ROA (TTM)
61.78%
Current Ratio
1.95

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Earnings

-14.3%Q1 2026$1.14
-40.5%Q2 2026$0.44
+903.9%Q3 2026$0.88
Next

Nov 3

in 54 daysQ4 2026

% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS

View full earnings history

About Rigel Pharmaceuticals, Inc.

Rigel Pharmaceuticals, Inc. is a NASDAQ-listed biotechnology company focused on commercial and clinical therapies for blood disorders, cancer, and immune-mediated disease. In FY2025, it recorded $294.3 million in revenue. Its marketed portfolio centers on medicines for defined hematology and oncology settings in the United States.

Name
Rigel Pharmaceuticals, Inc.
CEO
Raul R. Rodriguez
Website
www.rigel.com
Industry
Healthcare
Year Founded
1996
Employees
173

Today's Snapshot

AI-generated

RIGL opened 1.1% lower at 46.69, while its sector was flat.

Trading Volume

Below 10d avg (182.1K)

11.3K

vs S&P 500 Today

Inline with Market

+0.00%

Updated: September 10, 2026 at 14:45 UTC

Technical Indicators

4 Buy3 Neutral1 Sell
RIGL shows a constructive medium-term setup driven by a strong ADX reading that signals a meaningful trend while price sits below the short 10-period averages but above the 20- and longer-term moving averages, indicating recent pullback within an uptrend. Momentum indicators are mixed — RSI is neutral and MACD is flat while short-term momentum is weak — and volume is a concern given a large negative OBV. Volatility is moderate as ATR measures a few percent of price. Technical takeaway: Buy bias supported by trend strength and alignment with medium- and long-term moving averages.
All signals
  • EMA (5 indicators)$37.51 - $47.08
    Buy
  • RSI (14)55.99
    Neutral
  • Stochastic %K (14, 3, 3)47.24
    Neutral
  • MACD Level (12, 26)1.80
    Neutral

Peers & Related Assets

OMEROmeros Corporation
$19.39+1.4%
CRVSCorvus Pharmaceuticals, Inc.
$13.33-4.3%
OLMAOlema Pharmaceuticals, Inc.
$10.36-5.7%
FDMT4D Molecular Therapeutics, Inc.
$14.18-3.1%
PRTAProthena Corporation plc
$9.3-2.5%
AKBAAkebia Therapeutics, Inc.
$0.95-7.4%
Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.